Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / CYTH - Cyclo Therapeutics: A Potential Gem In The Fight Against Alzheimer's Disease

CYTH - Cyclo Therapeutics: A Potential Gem In The Fight Against Alzheimer's Disease

Cyclo Therapeutics Inc.
  • Cyclo Therapeutics' lead compound is a hydrogen peroxide and peroxynitrite scavenger which may help in the treatment of Alzheimer's disease and other neurological conditions.
  • Trappsol Cyclo appeared to either stabilize or produce improvements in Niemann-Pick type C disease patients, but with some potential hearing loss.
  • The drug also appeared to stabilize Alzheimer's disease in one patient at eighteen months.
  • This is a lightly traded company with major clinical trials ahead of it, so it is difficult to know at this point how the company plans to cover expenses.

For further details see:

Cyclo Therapeutics: A Potential Gem In The Fight Against Alzheimer's Disease
Stock Information
Company Name: Cyclo Therapeutics Inc.
Stock Symbol: CYTH
Market: NASDAQ
Website: cyclodex.com
Menu
CYTH CYTH Quote CYTH Short CYTH News CYTH Articles CYTH Message Board
Get CYTH Alerts

News, Short Squeeze, Breakout and More Instantly...